Old Web
English
Sign In
Acemap
>
authorDetail
>
Hirari Yamahana
Hirari Yamahana
University of Tokushima
Matrix metalloproteinase
Chemistry
Cell
Pharmacology
Cancer research
5
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TGF-β1 facilitates MT1-MMP-mediated proMMP-9 activation and invasion in oral squamous cell carcinoma cells
2021
Biochemistry and biophysics reports
Hirari Yamahana
Minoru Terashima
Risa Takatsuka
Chikako Asada
Takeshi Suzuki
Yoshihiro Uto
Takahisa Takino
Show All
Source
Cite
Save
Citations (0)
Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors.
2021
Chemical & Pharmaceutical Bulletin
Hirari Yamahana
Yuki Komiya
Takahisa Takino
Yoshio Endo
Hisatsugu Yamada
Chikako Asada
Yoshihiro Uto
Show All
Source
Cite
Save
Citations (0)
Erratum: TGF-β1 facilitates MT1-MMP-mediated proMMP-9 activation and invasion in oral squamous cell carcinoma cells (BBREP_101072).
2021
Biochemistry and biophysics reports
Hirari Yamahana
Minoru Terashima
Risa Takatsuka
Chikako Asada
Takeshi Suzuki
Yoshihiro Uto
Takahisa Takino
Show All
Source
Cite
Save
Citations (0)
Development of a novel acetyl glucose-modified gefitinib derivative to enhance the radiosensitizing effect.
2021
Bioorganic & Medicinal Chemistry
Hirari Yamahana
Yukari Kunieda
Masahide Tominaga
Hisatsugu Yamada
Yoshihiro Uto
Show All
Source
Cite
Save
Citations (0)
A novel celecoxib analog UTX-121 inhibits HT1080 cell invasion by modulating membrane-type 1 matrix metalloproteinase
2019
Biochemical and Biophysical Research Communications
Hirari Yamahana
Takahisa Takino
Yoshio Endo
Hisatsugu Yamada
Takeshi Suzuki
Yoshihiro Uto
Show All
Source
Cite
Save
Citations (1)
1